CAPRICOR THERAPEUTICS INC - COM (CAPR)

CUSIP: 14070B101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
752,964
Share change
-141,387
Total reported value
$627,000
Price per share
$0.83
Number of holders
16
Value change
-$349,485
Number of buys
6
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 14070B101?
CUSIP 14070B101 identifies CAPR - CAPRICOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CAPRICOR THERAPEUTICS INC - COM (CAPR) as of Q2 2017

As of 30 Jun 2017, CAPRICOR THERAPEUTICS INC - COM (CAPR) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 752,964 shares. The largest 10 holders included LLBH Private Wealth Management, LLC, Virtu KCG Holdings LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Apriem Advisors, Frontier Wealth Management LLC, GOLDMAN SACHS GROUP INC, Granite Point Capital Management, L.P., SABBY MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.